Loading...
This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.
Click here to view the deleted recordThis document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Internationally Recognized Certificates of Compliance
(IRCC)
last updated: 17 Apr 2018
ABSCH-IRCC-IN-239839-1
Competent National Authority:National Biodiversity Authority ()5th Floor, TICEL Biopark, CSIR Road, TaramaniChennai, Tamilnadu
600 113, IndiaPhone: +91 44 2254 2777,Fax: +91 44 2254 1200,Website: http://www.nbaindia.org,
India/NBA/Appl/9/466
Application in Form-III for seeking approval for the invention" A poly-herbal formulation for wound healing and a process for producing the same" for obtaining IP Rights in India.
Indian Patent number: 270519
15 Dec 2014
Yes
Competent National Authority:National Biodiversity Authority ()5th Floor, TICEL Biopark, CSIR Road, TaramaniChennai, Tamilnadu
600 113, IndiaPhone: +91 44 2254 2777,Fax: +91 44 2254 1200,Website: http://www.nbaindia.org,
Confidential information
Jorhat, AssamOrganization:Assam Agricultural University ()
785013, IndiaPhone: +91 376 2340008,Fax: +91 376 2340001,Email: registrar@aau.ac.in,Website:
Confidential information
Yes
1.If the user himself commercializes the process/product/innovation, he shall pay royalty @ 3% of the highest ex-factory sale price of the product(s) sold or used for captive consumption.
2. The user needs to inform the NBA about any commercialization made on the IP Rights granted.
3. The user shall submit the half-yearly report to NBA as per the terms and conditions agreed upon.
For obtaining IP Rights on the Invention “A poly-herbal formulation for wound healing and a process for producing the same" in India
Biological Resources:
Alternanthera brasiliana -Leaves
Achyranthes aspera - Leaves
Confidential information
- Commercial
1. In case the user assigns/licenses the innovation/ process/ product to a third party for commercialization:
The user shall pay 5% of the fee received by him in any form (including the license fee / assignee fee). The user shall also pay 5% of the annual royalty amount received by him, on an annual basis, from the assignee/ licensee throughout the term of the agreement.
OR
The assignee/licensee shall enter into a tripartite agreement with the user and the NBA, to pay 5% of the lump sum payment made by him to the licensor and also royalty @ 5% of the highest
ex-factory sale price of the product sold and used for captive consumption to NBA.
ex-factory sale price of the product sold and used for captive consumption to NBA.
2. In case, the user assigns or transfers the IPR in whole or in part to any person, whether voluntarily or involuntarily, the user undertakes to attach this agreement as an appendix to the assignment instrument which shall be binding upon such person.
| Unique identifier | Status | Date |
|---|---|---|
| ABSCH-IRCC-IN-239839-1 |
REVOKED
OLD VERSION
PUBLISHED
DELETED
|
Sujata Arora (sujata@nic.in)
17 Apr 2018 06:14 on 17 Apr 2018 06:14
|
